[go: up one dir, main page]

ATE174800T1 - Dendrimere polychelate - Google Patents

Dendrimere polychelate

Info

Publication number
ATE174800T1
ATE174800T1 AT92920822T AT92920822T ATE174800T1 AT E174800 T1 ATE174800 T1 AT E174800T1 AT 92920822 T AT92920822 T AT 92920822T AT 92920822 T AT92920822 T AT 92920822T AT E174800 T1 ATE174800 T1 AT E174800T1
Authority
AT
Austria
Prior art keywords
polychelate
conjugated
site
dendrimere
macrocyclic chelant
Prior art date
Application number
AT92920822T
Other languages
English (en)
Inventor
Alan D Watson
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Application granted granted Critical
Publication of ATE174800T1 publication Critical patent/ATE174800T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Polyamides (AREA)
  • Medicinal Preparation (AREA)
AT92920822T 1991-10-07 1992-10-06 Dendrimere polychelate ATE174800T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/772,349 US5914095A (en) 1989-04-07 1991-10-07 Polychelants containg amide bonds

Publications (1)

Publication Number Publication Date
ATE174800T1 true ATE174800T1 (de) 1999-01-15

Family

ID=25094771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92920822T ATE174800T1 (de) 1991-10-07 1992-10-06 Dendrimere polychelate

Country Status (9)

Country Link
US (1) US5914095A (de)
EP (1) EP0607222B1 (de)
JP (1) JPH07503031A (de)
AT (1) ATE174800T1 (de)
AU (1) AU671601B2 (de)
CA (1) CA2120763A1 (de)
DE (1) DE69227998T2 (de)
SG (1) SG48985A1 (de)
WO (1) WO1993006868A1 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072934C (en) * 1991-07-19 2007-08-28 Karl William Aston Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
US5898005A (en) * 1993-02-24 1999-04-27 Dade Behring Inc. Rapid detection of analytes with receptors immobilized on soluble submicron particles
US6121056A (en) * 1993-02-24 2000-09-19 Dade Behring Inc. Random detection of antigens with antibodies immobilized on soluble submicron particles
CA2133967A1 (en) * 1993-02-24 1994-09-01 Spencer H. Lin Immobilization of specific binding assay reagents
GB9404208D0 (en) * 1994-03-04 1994-04-20 Nycomed Salutar Inc Chelants
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
WO1995028967A1 (en) * 1994-04-20 1995-11-02 Nycomed Salutar Inc Contrast agents
DE4425857A1 (de) 1994-07-07 1996-01-11 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel
EP0709100A1 (de) * 1994-09-30 1996-05-01 Nihon Medi-Physics Co., Ltd. Kontrastmittel mit mehreren Detektionsgruppen pro Molekül
US5558968A (en) * 1995-01-26 1996-09-24 Hewlett-Packard Company Dendrimeric toner particles for liquid electrophotography
US6770261B2 (en) * 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US6713045B1 (en) 1995-06-02 2004-03-30 Research Corporation Technologies, Inc. Targeted magnetic resonance imaging agents for the detection of physiological processes
US6525041B1 (en) 1995-06-06 2003-02-25 Pharmacia Corporation Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
US5801228A (en) * 1995-06-07 1998-09-01 Nycomed Imaging As Polymeric contrast agents for medical imaging
US6083708A (en) * 1995-08-11 2000-07-04 Dade Behring Inc. Polypeptide: dendrimer complexes
AU6896796A (en) 1995-08-17 1997-03-12 Monsanto Company Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
WO1998032469A2 (en) * 1997-01-29 1998-07-30 Nycomed Imaging As Polymers
WO1998056427A1 (fr) * 1997-06-12 1998-12-17 Mitsubishi Chemical Corporation Agent de contrast
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
US7632651B2 (en) 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
WO1999025389A2 (en) * 1997-11-17 1999-05-27 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
US5938934A (en) * 1998-01-13 1999-08-17 Dow Corning Corporation Dendrimer-based nanoscopic sponges and metal composites
AUPP584398A0 (en) * 1998-09-14 1998-10-08 Starpharma Limited Inhibition of toxic materials or substances
AU6386000A (en) * 1999-07-29 2001-02-19 Epix Pharmaceuticals, Inc. Targeting multimeric imaging agents through multilocus binding
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
US20040146463A1 (en) * 2000-05-04 2004-07-29 Meade Thomas J. Functional MRI agents for cancer imaging
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
AU2001276956A1 (en) 2000-07-17 2002-01-30 California Institute Of Technology Macrocyclic mri contrast agents
US7029655B2 (en) 2000-10-04 2006-04-18 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
EP1390079A2 (de) 2000-11-20 2004-02-25 Board of Regents University of Texas System Paramagnetischen metallion-basierte makrozyklische kontrastmitteln
US6517814B2 (en) 2001-01-09 2003-02-11 Bristol-Myers Squibb Pharma Company Macrocyclic chelants useful for metallopharmaceuticals
CN1622832A (zh) 2001-02-23 2005-06-01 布里斯托尔-迈尔斯斯奎布药品公司 用于动脉粥样硬化和易病变性斑块成像的标记的巨噬细胞清除剂受体拮抗剂
US20030004236A1 (en) * 2001-04-20 2003-01-02 Meade Thomas J. Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
WO2002087632A1 (en) * 2001-05-02 2002-11-07 Metaprobe, Inc. High throughput screening methods using magnetic resonance imaging agents
WO2003001218A2 (en) * 2001-06-25 2003-01-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Macromolecular imaging agents for liver imaging
TWI221406B (en) * 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
US6852842B2 (en) * 2002-08-26 2005-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for functional kidney imaging using small dendrimer contrast agents
CA2499573A1 (en) 2002-09-24 2004-04-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for convection enhanced delivery of therapeutic agents
US20040258614A1 (en) * 2003-06-20 2004-12-23 University Of Maryland, Baltimore Microparticles for microarterial imaging and radiotherapy
AR047692A1 (es) * 2003-07-10 2006-02-08 Epix Medical Inc Imagenes de blancos estacionarios
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents
CA2581639C (en) 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
US20060204443A1 (en) * 2005-03-11 2006-09-14 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for tumor treatment using dendrimer conjugates
CN101166547B (zh) * 2005-04-26 2013-02-06 皇家飞利浦电子股份有限公司 包含cest活性的顺磁性配合物的mri造影剂
PT2444804E (pt) 2006-05-27 2015-11-25 Fluidigm Canada Inc Marcadores elementares da cadeia principal de polímeros
EP2057131B1 (de) * 2006-08-30 2013-08-21 Ge Healthcare As Dynamisches nukleares polarisationsverfahren sowie verbindungen und zusammensetzungen zur verwendung für das verfahren
DE102007002726A1 (de) * 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
DE102008045937B4 (de) * 2008-04-11 2017-01-26 Johannes-Gutenberg-Universität Mainz Radiopharmakon aus einem Metallion und einem Markierungsvorläufer und Verwendung des Radiopharmakons
EP2147684A1 (de) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Selektiv gegen Metallproteasen wirkende Diagnosemittel
US8524457B2 (en) 2009-09-22 2013-09-03 William Patterson Method for the selection of specific affinity binders by homogeneous noncompetitive assay
US9125942B2 (en) 2010-01-19 2015-09-08 Northwestern University Paramagnetic metal-nanodiamond conjugates
ITMI20101054A1 (it) * 2010-06-11 2011-12-12 Carlo Ghisalberti Composizioni e sistemi di sequestro ed immunodisattivazione di nichel e cobalto
US20120271100A1 (en) 2011-04-14 2012-10-25 Northwestern University Compositions and methods for the detection of zinc
WO2013134686A1 (en) 2012-03-09 2013-09-12 Promega Corporation pH SENSORS
US20140134665A1 (en) 2012-11-15 2014-05-15 Northwestern University Compositions and methods for the detection of zinc
US9551705B2 (en) 2012-12-12 2017-01-24 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
US10168323B2 (en) 2013-03-15 2019-01-01 Promega Corporation Compositions and methods for capture of cellular targets of bioactive agents
EP4169935A1 (de) 2013-03-15 2023-04-26 Promega Corporation Aktivierung von biolumineszenz durch strukturelle komplementierung
AU2015222881A1 (en) 2014-02-27 2016-08-04 The Procter & Gamble Company Method for evaluating bioavailable zinc
JP6669670B2 (ja) 2014-05-15 2020-03-18 クリーヴランド ハートラボ インコーポレイテッド Ｈｄｌ及びａｐｏａ１の精製及び検出のための組成物及び方法
US10590162B2 (en) 2014-07-02 2020-03-17 Promega Corporation Reversible metal ion chelators
WO2016040835A1 (en) 2014-09-12 2016-03-17 Promega Corporation Internal protein tags
WO2016210290A1 (en) 2015-06-26 2016-12-29 Northwestern University Gd(III)-DITHIOLANE GOLD NANOPARTICLE CONJUGATES
WO2018106937A1 (en) 2016-12-07 2018-06-14 The University Of Chicago Compositions and methods for inhibition of foxp3
WO2018156602A1 (en) 2017-02-21 2018-08-30 The Regents Of The University Of Michigan Il-22bp compositions and method for the treatment of disease therewith
JP7584433B2 (ja) 2019-03-20 2024-11-15 プロメガ コーポレイション 光親和性プローブ
US11360096B2 (en) 2019-05-16 2022-06-14 Duke University Complex BRET technique for measuring biological interactions
EP4065699A1 (de) 2019-11-27 2022-10-05 Promega Corporation Mehrteilige luciferase-peptide und polypeptide
EP4519385A2 (de) 2022-05-04 2025-03-12 Promega Corporation Biolumineszenzausgelöste photokatalytische markierung
CN118949667B (zh) * 2024-10-16 2025-01-14 明硕环境科技集团股份有限公司 一种高效复合脱硫剂及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4587329A (en) * 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
US4871779A (en) * 1985-12-23 1989-10-03 The Dow Chemical Company Ion exchange/chelation resins containing dense star polymers having ion exchange or chelate capabilities
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
AU593611B2 (en) * 1986-02-14 1990-02-15 Nihon Medi-Physics Co., Ltd. High molecular compounds having amino groups, and their utilization
US5338532A (en) * 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
EP0271180B2 (de) * 1986-08-18 1997-06-18 The Dow Chemical Company Conjugate dichter Sterne
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
DE3728525A1 (de) * 1987-08-24 1989-03-16 Schering Ag Mehrkernige substituierte komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US4857599A (en) * 1988-02-08 1989-08-15 The Dow Chemical Company Modified dense star polymers
US4923985A (en) * 1988-05-25 1990-05-08 The United States Of America As Represented By The Department Of Health & Human Services Process for synthesizing macrocyclic chelates
ES2013978A4 (es) * 1988-06-24 1990-06-16 Dow Chemical Co Compuestos de enlace ionico bifuncionales macrociclicos, complejos de ellos y sus anticuerpos conjugados
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
JP2865112B2 (ja) * 1989-05-26 1999-03-08 アクゾ・エヌ・ヴエー 金属イオンをタンパク質に結合するためのキレート化剤
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4115789A1 (de) * 1991-05-10 1992-11-12 Schering Ag Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
HK1002101A1 (en) 1998-07-31
DE69227998D1 (de) 1999-02-04
US5914095A (en) 1999-06-22
EP0607222A1 (de) 1994-07-27
EP0607222B1 (de) 1998-12-23
DE69227998T2 (de) 1999-08-19
WO1993006868A1 (en) 1993-04-15
CA2120763A1 (en) 1993-04-15
AU2675792A (en) 1993-05-03
SG48985A1 (en) 1998-05-18
AU671601B2 (en) 1996-09-05
JPH07503031A (ja) 1995-03-30

Similar Documents

Publication Publication Date Title
ATE174800T1 (de) Dendrimere polychelate
DE69027603D1 (de) Chelatbildner
NO954434L (no) Bioaktive og/eller målsökende dendrimer-konjugater
DK0959905T3 (da) Polysaccharid-peptid-konjugater
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
CA2158054A1 (en) Conjugates of proteins and bifunctional ligands
ATE304867T1 (de) Wasserlösliche paclitaxel konjugate kombiniert mit bestrahlung zur behandlung von krebs
WO2002087498A3 (en) Diagnostic imaging compositions, their methods of synthesis and use
DK0586524T3 (de)
NO944019D0 (no) Karboksamid-modifiserte polyamin-chelatorer og radioaktive komplekser og konjugater
EP1683520A3 (de) Wasserlösliche Paclitaxel-Prodrogen
DE68922368D1 (de) Chelatbildner, die eine ortho-bindende funktionelle Gruppe besitzen und Komplexe davon.
EP1071443A4 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
BR9709720A (pt) Formamidas, acetamidas e propionamidas indezil benzilideno substituìdas
DK0570575T3 (da) Bicykloazamakrocyklophosphonsyre, komplekser, konjugater, kontrastmidler og fremstilling heraf
AU3448497A (en) Conjugates of an oligonucleotide/electronic conductor polymer with a molecule of interest, and their uses
DE59610242D1 (de) Zaunpfosten
DE69014655D1 (de) Schlagfeste Polymermischungen aus Polyamiden, Anhydridcopolymeren und funktionalisierten Elastomeren.
ATE313796T1 (de) Konjugate definierter stöchiometrie
ATE214631T1 (de) Konjugat, geeignet zur bindung von substanzen
Fredericks With the house
RU93057952A (ru) Биологический активный макромолекулярный конъюгат, гидразинсодержащие конъюгаты полипептидов и гликополипептидов с полимерами
Burke The potential impact of the North American Free Trade Agreement on international trade in banking services: a Canadian perspective.
MY116630A (en) Bioactive and/or targeted dendrimer conjugates

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties